Friedrich Graf Finckenstein, M.D.

Friedrich Graf Finckenstein, M.D.

Chief Medical OfficeratIovance Biotherapeutics· In proxies 2021–2024

Pay in FY2024+88% from the year before · Iovance Biotherapeutics stock -9.0% the same year

Friedrich Graf Finckenstein, M.D. was paid $3.3M in FY2024 (Dec), up 88%. Iovance Biotherapeutics stock fell 9.0% that year.

Pay$100 in the stock at the end of FY20 → $16
Pay is from the Summary Compensation Table of each Iovance Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Iovance BiotherapeuticsPublic company · 5 yr
    • Chief Medical Officer2021 – Present · 5 yrStock in role -70%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?